cas 63460-47-9|| where to buy 2-(4-iodopentyl)isoindole-1,3-dione

Produktname:2-(4-iodopentyl)isoindole-1,3-dione

IUPAC Name:2-(4-iodopentyl)-2,3-dihydro-1H-isoindole-1,3-dione

Packungseinheit	Verfügbarer Vorrat	Preis($)	Menge

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 63460-47-9 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:63460-47-9; Molekulare Formel:C13H14INO2; Schmelzpunkt:-; SMILES-Code:O=C1N(CCCC(I)C)C(C2=C1C=CC=C2)=O; Dichte:

: Katalognummer:CM341453; Molekulargewicht:343.16; Siedepunkt:; Mdl-Nr.:; Lagerung:

: Tafenoquine; 60 Degrees Pharmaceuticals recently announced it has entered into an agreement with Tufts Medical Center in Boston to conduct the world’s first clinical trial evaluating the efficacy and safety of tafenoquine in treating human babesiosis patients. The FDA has granted its investigational tafenoquine candidate orphan drug designation for the treatment of patients with acute babesiosis.
Tafenoquine was approved for malaria prophylaxis in 2018 in the United States as ARAKODA and in Australia as KODATEF. It is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years of age and older.